检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
11期
1496-1498
,共3页
陶涛%赵琴%庞洪波%李雪芹
陶濤%趙琴%龐洪波%李雪芹
도도%조금%방홍파%리설근
脑梗死%瑞舒伐他汀%血脂%血液流变学
腦梗死%瑞舒伐他汀%血脂%血液流變學
뇌경사%서서벌타정%혈지%혈액류변학
infarction%rosuvastatin%lipids%rheology
目的:通过观察瑞舒伐他汀对脑梗死患者血脂和血液流变学的影响,探讨其临床意义。方法收集2012年3月至2013年2月芜湖市第二人民医院神经内科收治的脑梗死住院患者124例,按随机数字表格法分为观察组与对照组,各62例。两组患者根据病情及并发症的不同,合理给予抗凝药、抗血小板聚集剂、脱水剂、降糖药、降压药、护脑、改善微循环及抗感染药物;观察组在上述基础上加用瑞舒伐他汀片,比较两组治疗前后血脂、血液流变学及临床疗效。结果与对照组比较,观察组患者治疗后,胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)均明显降低(t=2.898、9.635、6.377,P<0.05),高密度脂蛋白(HDL)则明显升高(t=2.091,P<0.05);高切及低切全血比黏度、纤维蛋白原均明显降低(t=3.670、8.067、6.898,P<0.05);观察组与对照组的总有效率分别为83.9%和71.0%,两组比较差异有统计学意义(χ2=4.846,P<0.05)。结论瑞舒伐他汀能明显改善脑梗死患者的血脂及血液流变学,具有临床意义。
目的:通過觀察瑞舒伐他汀對腦梗死患者血脂和血液流變學的影響,探討其臨床意義。方法收集2012年3月至2013年2月蕪湖市第二人民醫院神經內科收治的腦梗死住院患者124例,按隨機數字錶格法分為觀察組與對照組,各62例。兩組患者根據病情及併髮癥的不同,閤理給予抗凝藥、抗血小闆聚集劑、脫水劑、降糖藥、降壓藥、護腦、改善微循環及抗感染藥物;觀察組在上述基礎上加用瑞舒伐他汀片,比較兩組治療前後血脂、血液流變學及臨床療效。結果與對照組比較,觀察組患者治療後,膽固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)均明顯降低(t=2.898、9.635、6.377,P<0.05),高密度脂蛋白(HDL)則明顯升高(t=2.091,P<0.05);高切及低切全血比黏度、纖維蛋白原均明顯降低(t=3.670、8.067、6.898,P<0.05);觀察組與對照組的總有效率分彆為83.9%和71.0%,兩組比較差異有統計學意義(χ2=4.846,P<0.05)。結論瑞舒伐他汀能明顯改善腦梗死患者的血脂及血液流變學,具有臨床意義。
목적:통과관찰서서벌타정대뇌경사환자혈지화혈액류변학적영향,탐토기림상의의。방법수집2012년3월지2013년2월무호시제이인민의원신경내과수치적뇌경사주원환자124례,안수궤수자표격법분위관찰조여대조조,각62례。량조환자근거병정급병발증적불동,합리급여항응약、항혈소판취집제、탈수제、강당약、강압약、호뇌、개선미순배급항감염약물;관찰조재상술기출상가용서서벌타정편,비교량조치료전후혈지、혈액류변학급림상료효。결과여대조조비교,관찰조환자치료후,담고순(TC)、삼선감유(TG)、저밀도지단백(LDL)균명현강저(t=2.898、9.635、6.377,P<0.05),고밀도지단백(HDL)칙명현승고(t=2.091,P<0.05);고절급저절전혈비점도、섬유단백원균명현강저(t=3.670、8.067、6.898,P<0.05);관찰조여대조조적총유효솔분별위83.9%화71.0%,량조비교차이유통계학의의(χ2=4.846,P<0.05)。결론서서벌타정능명현개선뇌경사환자적혈지급혈액류변학,구유림상의의。
Objective To observe the impact of rosuvastatin on the blood rheology and lipid in patients with cerebral infarction ,and to explore its clinical significance .Methods 124 cases of cerebral infarction patents were di-vided into observation group and control group from March 2012 to February 2013 .Two groups of patients were rea-sonable given anticoagulants ,dehydrating agent ,hypoglycemic agents ,antihypertensive drugs ,protecting the brain , improve microcirculation and anti-infectives accorded to the disease and its complications .Based on the above observa-tion group plus statin rosuvastatin calcium tablets .Blood lipids ,blood rheology and clinical efficacy in the two groups were compared before and after treatment .Results Compared with the control group ,the observation group after treatment .The TC ,TG ,LDL of the observation group were significantly lower (t=2 .898 ,9 .635 ,6 .377 ,P<0 .05) , HDL of them is increased significantly (t=2 .091 ,P<0 .05) .High cut and low-cut whole blood viscosity and fibrino-gen were significantly lower(t=3 .670 ,8 .067 ,6 .898 ,P<0 .05) .Observation group and control group ,the effective rates of observation group and control group were 83 .9% and 71 .0% respectively ,the difference was statistically significant(χ2 =4 .846 ,P<0 .05) .Conclusion Rosuvastatin can significantly improve blood lipid and blood rheology for patients with cerebral infarction ,efficacy ,adverse reactions ,worthy of promotion .